Ignace Vergote
Novocure Clinical Trial Investigator

Professor Ignace Vergote conducts 20 ovarian cancer trials per year and has authored more than 800 papers in gynecologic cancers. He was an investigator in Novocure’s phase 2 pilot trial in recurrent ovarian cancer, INNOVATE.

More

Ori Farber
Senior Medical Manager

Ori Farber, Senior Medical Manager, shares what it’s like to work behind the scenes on Novocure’s company-sponsored clinical trials.

More

Matt Lozano
Senior Device Support Specialist

Matt Lozano, a Novocure Senior Device Support Specialist, shares the meaning he finds in working with patients and their caregivers

More

Tomoe Kamata
Special Project Manager

Tomoe Kamata, Special Project Manager at Novocure Japan, uses her background in science and knack for interacting with people to market Novocure’s cancer therapy in Japan.

More

Novocure honors
Brain Tumor Awareness Month

As a member of the brain cancer community, Novocure took steps to support the initiative, raise awareness and encourage action.

More

Julia Schwarzenberger
Key Account Manager

Julia Schwarzenberger, a Key Account Manager in Germany, enjoys sharing information on Novocure’s treatment with health care providers and providing hope for cancer patients.

More

Novocure employees
honor caregivers

Novocure employees share the qualities they admire in caregivers of people who have cancer.

More

GBM in the
national spotlight

When high-profile people are diagnosed with this rare, yet aggressive disease, many patients feel empathy and hope for more progress.

More

Tobias Weizel
General Manager Germany

Tobias Weizel, Novocure’s General Manager Germany, leads the company’s commercial business in Germany and said he feels lucky to be a part of Novocure’s mission of bringing a profoundly different cancer treatment to patients worldwide.

More

Sharyn Ruperti
Clinical Trial Manager

Sharyn Ruperti, Clinical Trial Manager, discusses her 10-year career at Novocure. Read more about her views on the evolution of the company and what sets us apart.

More

Ze’ev Bomzon Director of Science

Our Director of Science, Ze’ev Bomzon, discusses his research on Tumor Treating Fields (TTFields). Learn more about his work to further the understanding of TTFields' mechanism of action.

More

innovation at work

Our second generation Optune System is smaller and less than half the weight of our first generation Optune System. See more on the innovation behind our redesigned Tumor Treating Fields delivery system.

More

Amy Luton, DSS

Our Device Support Specialists (DSSs) work one-on-one with patients — educating them about the device, and providing technical support and personal contact with Novocure. Learn more about Amy Luton, one of our DSSs in Texas.

More